TY - JOUR T1 - Disease Triangle Dynamics of Coccidioidomycosis in Northern Arizona JF - medRxiv DO - 10.1101/2021.06.24.21258773 SP - 2021.06.24.21258773 AU - Heather L. Mead AU - Dan Kollath AU - Marcus de Melo Teixeira AU - Chandler C. Roe AU - Paul K. Keim AU - Carmel Plude AU - Joel Terriquez AU - Nivedita Nandurkar AU - Chelsea Donohoo AU - Brettania L.W. O’Connor AU - Bridget M. Barker Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/06/28/2021.06.24.21258773.abstract N2 - Coccidioides species are the etiological agent of Valley fever (Vf). Disease ranges from pneumonia to extrapulmonary infection. If diagnosis is delayed or missed, the risk of severe disease increases. We investigate the disease triangle (intersection of pathogen, host, and environment) of Vf in Northern Arizona, where the risk of acquiring the disease is lower but prevalent and rising. We inspect reported and hospitalized cases of VF hosts. Then assess pathogen origin by comparing Northern Arizona clinical isolates to isolates from other regions. Lastly, we survey Northern Arizona soils for evidence of Coccidioides. We found that cases of Vf are increasing some requiring hospitalization. The Northern Arizona Coccidioidies isolates were genetically related to Southern Arizona populations. However, we detected Coccidioides DNA in Northern Arizona soils. We expect that cases will continue to increase and suggest increased awareness and screening for the disease is crucial to limit severe illness in Northern Arizona.Article Summary Line Our work is the first description of the Valley fever disease triangle in Northern Arizona, which considers the complex interaction between host, pathogen and environment in the region. Our data suggests that the prevalence of diagnosed cases is rising in the region, some of which are extreme enough to necessitate hospitalization. We present the first evidence of Coccidioides spp. in Northern Arizona soils, suggesting that the pathogen is maintained in the local environment. Until disease prevention is an achievable option via vaccination, we anticipate that incidence of Valley fever will rise in the area. Therefore, enhanced disease awareness and screening for the coccidioidomycosis is vital to the communities of Northern Arizona.Competing Interest StatementThe authors have declared no competing interest.Funding StatementB.M.B received funding for soil collection and analysis under ABRC 16‐162415. Sequencing funds were awarded to H.L.M by The Center for Ecosystem Science and Society (Ecoss) and the McAllister Program in Community, Culture and Environment at Northern Arizona University. Isolates were collected under IBR No. 764034 through Northern Arizona Healthcare as part of the Northern Arizona University Biobank. Funding for this biobank was provided by the Flinn Foundation of Arizona seed grant #1978 to P. Keim and J. Terriquez.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Samples collected under IRB No. 764034 as part of the Northern Arizona University Biobank study with Northern Arizona Healthcare.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRaw reads used in this study have been deposited under accession number PRJNA722304. ER -